Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2003
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468154A1 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
06/05/2003CA2468071A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003CA2468020A1 Osteopontin-related compositions and methods
06/05/2003CA2468016A1 Humanized collagen antibodies and related methods
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467854A1 Sir2 products and activities
06/05/2003CA2467664A1 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2467397A1 Flavivirus vaccine delivery system
06/05/2003CA2466867A1 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466807A1 Pharmaceutical formulations comprising indolinone derivatives
06/04/2003EP1316611A1 L-methionine gamma-lyase with modified function
06/04/2003EP1316607A1 Pseudo-cyclic oligonucleobases for inhibiting tumor growth
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1316558A1 Tetraphenylbacteriochlorin derivatives and compositions containing the same
06/04/2003EP1316547A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315760A2 Endoglin-specific polypeptide, production and use thereof
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315755A1 Anti-angiogenic peptides
06/04/2003EP1315752A1 Modified proteins, isolated novel peptides, and uses thereof
06/04/2003EP1315742A1 Amino acid substitution mutants of interleukin 13
06/04/2003EP1315736A2 Nucleoside derivatives for the treatment of hepatitis c
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315731A1 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
06/04/2003EP1315730A1 1-(alkyl), 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo(1,2-a)pyrimidin-5(1h)-one derivatives
06/04/2003EP1315727A2 7-oxo pyridopyrimidines
06/04/2003EP1315720A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315718A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315717A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315716A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315715A1 Quinazoline derivatives as kinase inhibitors
06/04/2003EP1315710A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315709A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315708A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315705A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315523A1 Vp22 protein / nucleic acid aggregates, uses thereof
06/04/2003EP1315520A2 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
06/04/2003EP1315519A2 Pharmaceutical compositions and methods useful for modulating angiogenesis
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315507A2 Hpv-specific short-mers
06/04/2003EP1315504A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
06/04/2003EP1315502A1 Method for treating erectile dysfunction and increasing libido in men
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1315498A2 Use of ectoin or ectoin derivatives for stabilizing p53
06/04/2003EP1315486A2 Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor
06/04/2003EP1315484A1 Taxane-based compositions and methods of use
06/04/2003EP1315483A2 Combined estrogen blockade of the breast with exemestane and raloxifene
06/04/2003EP1315482A2 Water-dispersible encapsulated sterols
06/04/2003EP1315480A2 "slow release" pharmaceutical compositions comprising lithium carbonate
06/04/2003EP1315475A1 Lung surfactant compositions with dynamic swelling behaviour
06/04/2003EP1282609A4 Piperazinedione compounds
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1214347B1 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
06/04/2003EP1200099B1 Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds
06/04/2003EP1165565B1 Optically pure camptothecin analogues
06/04/2003EP1126782A4 Method for improved imaging and photodynamic therapy
06/04/2003EP1107751B1 Medicament containing platinum complex compounds and the use thereof
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP1028721B1 N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
06/04/2003EP0994111B1 Tetrahydrofuran derivatives
06/04/2003EP0977557B1 Pellet-type formulation intended for treating the intestinal tract
06/04/2003EP0970084B1 Pyrrolo 2,3d]pyrimidines and their use as tyrosine kinase inhibitors
06/04/2003EP0966439B1 Certain cyclic thio substituted acylaminoacid amide derivatives
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0938496B1 Heptapeptide oxytocin analogues
06/04/2003EP0910357B1 Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression
06/04/2003EP0909175B1 Non-aqueous protic peptide formulations
06/04/2003EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
06/04/2003EP0819120B1 Tricyclic compounds useful for inhibition of farnesyl protein transferase
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
06/04/2003CN1422333A Polypeptide inducing apoptosis
06/04/2003CN1422332A Human ovarian mesothelial cells and methods of isolation and uses thereof
06/04/2003CN1422283A Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
06/04/2003CN1422281A G-protein coupled receptors
06/04/2003CN1422278A kahalalide F及相关化合物 kahalalide F and related compounds
06/04/2003CN1422277A Novel substance having physiological activity, process for producing the same, and use
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422268A 5-alkylpyrido [2,3-D] pyrimidines tyrosine kinase inhibitors
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
06/04/2003CN1422253A Carbamate caspase inhibitors and uses thereof
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1422163A Formulation solubilizing water-insoluble agents and preparation method thereof
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1422154A The treatment of respiratory diseases
06/04/2003CN1421460A Conjugate of lidamycin, monoclonal antibody and its Fab'segment and its application in targeting treatment of colon cancer and other tumors
06/04/2003CN1421459A Humanized CD3-resisting monoclonal antibody
06/04/2003CN1421457A New human protein with cancer cell growth inhibiting function and its coding sequence
06/04/2003CN1421456A Human apolipoprotein polypeptide and its use in resisting vascular proliferation diseases
06/04/2003CN1421452A Structure and prepn of 2,6-branched oligosaccharide with medicinal application foreground
1 ... 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 ... 2211